These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27939484)

  • 1. Strong inhibitory effect of pre-eclampsia serum on angiogenesis detected in vitro by human cell-based angiogenesis tests.
    Virtanen A; Toimela T; Tihtonen K; Sarkanen JR; Huttala O; Heinonen T; Uotila J
    Pregnancy Hypertens; 2016 Oct; 6(4):367-373. PubMed ID: 27939484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesis/angiogenesis test.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Uotila J
    Angiogenesis; 2019 Feb; 22(1):67-74. PubMed ID: 30003436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Laivuori H; Uotila J
    Pregnancy Hypertens; 2020 Oct; 22():7-13. PubMed ID: 32682321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic Effect of Pravastatin Alone and with Sera from Healthy and Complicated Pregnancies Studied by in vitro Vasculogenesis/Angiogenesis Assay.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Laivuori H; Uotila J
    J Vasc Res; 2021; 58(3):139-147. PubMed ID: 33571991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.
    Sezer SD; Küçük M; Yenisey C; Yüksel H; Odabaşı AR; Türkmen MK; Çetinkaya Çakmak B; Ömürlü IK
    Gynecol Endocrinol; 2012 Aug; 28(8):628-32. PubMed ID: 22429154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
    Schlembach D; Wallner W; Sengenberger R; Stiegler E; Mörtl M; Beckmann MW; Lang U
    Ultrasound Obstet Gynecol; 2007 Apr; 29(4):407-13. PubMed ID: 17330322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and umbilical cord blood levels of leptin in pre-eclamptic and healthy pregnant women: A comparative cross-sectional study.
    Okafor LU; Eleje GU; Ikechebelu JI; Ugwu EO; Nwosu OB; Ikpeze OC; Udigwe GO; Eke AC; Okoli SA; Oguejiofor CB; Ogabido CA; Malachy DE; Ofor IJ; Okafor CG
    Womens Health (Lond); 2023; 19():17455057231213272. PubMed ID: 38047453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns.
    Deniz R; Baykus Y; Ustebay S; Ugur K; Yavuzkir Ş; Aydin S
    J Obstet Gynaecol; 2019 Oct; 39(7):907-912. PubMed ID: 31064239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
    Dong YL; Chauhan M; Green KE; Vegiraju S; Wang HQ; Hankins GD; Yallampalli C
    Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
    Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
    J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia.
    Xia L; Zhou XP; Zhu JH; Xie XD; Zhang H; Wang XX; Chen JZ; Jian S
    J Obstet Gynaecol Res; 2007 Aug; 33(4):465-74. PubMed ID: 17688613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential levels of interleukin 6 in maternal and cord sera and placenta in women with pre-eclampsia.
    Al-Othman S; Omu AE; Diejomaoh FM; Al-Yatama M; Al-Qattan F
    Gynecol Obstet Invest; 2001; 52(1):60-5. PubMed ID: 11549867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired functional capacity of fetal endothelial cells in preeclampsia.
    Brodowski L; Burlakov J; Hass S; von Kaisenberg C; von Versen-Höynck F
    PLoS One; 2017; 12(5):e0178340. PubMed ID: 28542561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia.
    Yan JY; Jiang LL
    J Obstet Gynaecol Res; 2015 Jun; 41(6):843-9. PubMed ID: 25656432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor.
    Kakigano A; Tomimatsu T; Mimura K; Kanayama T; Fujita S; Minato K; Kumasawa K; Taniguchi Y; Kanagawa T; Endo M; Ishihara T; Namba T; Mizushima T; Kimura T
    Reprod Sci; 2015 Oct; 22(10):1272-80. PubMed ID: 25736325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells.
    Sandrim VC; Dias MC; Bovolato AL; Tanus-Santos JE; Deffune E; Cavalli RC
    J Cell Mol Med; 2016 Jun; 20(6):1198-200. PubMed ID: 27012926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of maternal and umbilical cord blood HIF-1α and nitric oxide levels in early and late onset preeclamptic pregnancies.
    Demircan Sezer S; Küçük M; Nergiz Avcıoğlu S; Zafer E; Altınkaya SÖ; Bıçakçı B; Yenisey Ç; Yüksel H; Kurt Ömürlü İ
    Gynecol Endocrinol; 2015; 31(12):945-8. PubMed ID: 26172929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia.
    Shaamash AH; Elsnosy ED; Makhlouf AM; Zakhari MM; Ibrahim OA; EL-dien HM
    Int J Gynaecol Obstet; 2000 Mar; 68(3):207-14. PubMed ID: 10699190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.